Variable / Field Name,Form Name,Section Header,Field Type,Field Label,"Choices, Calculations, OR Slider Labels",Field Note,Text Validation Type OR Show Slider Number,Text Validation Min,Text Validation Max,Identifier?,Branching Logic (Show field only if...),Required Field?,Custom Alignment,Question Number (surveys only),Matrix Group Name,Matrix Ranking?,Field Annotation
unique_subject_id,subject_identifier,,text,Unique Subject ID,,,,,,,,,,,,, @READONLY
sex,demographics,,dropdown,Sex,"1, Male | 2, Female | 9999, Unknown | 9998, Other | 9997, Not reported",The biologic sex of the subject,autocomplete,,,,,y,,,,,
race,demographics,,dropdown,Race,"1, American Indian or Alaska Native | 2, Asian | 3, Black or African American | 4, Multiracial | 5, Native Hawaiian or Other Pacific Islander | 6, White | 9998, Other | 9999, Unknown | 9997, Not reported",The race of the subject,autocomplete,,,,,y,,,,,
ethnicity,demographics,,dropdown,Ethnicity,"1, Hispanic or Latino | 2, Not Hispanic or Latino | 9999, Unknown | 9997, Not reported",The ethnicity or ethnic group of the subject,autocomplete,,,,,y,,,,,
enrollment_age,demographics,,text,Age at enrollment (in months),,,,,,,,,,,,, @READONLY
age_at_anthropometrics,anthropometrics,,text,Age at anthropometrics (in months),,,,,,,,y,,,,, @READONLY
weight,anthropometrics,,text,Weight,,{weight_unit},number,,,,,y,RH,,,,
weight_unit,anthropometrics,,radio,Weight unit ,"1, lbs | 2, kg",,,,,,,y,RH,,,,
height,anthropometrics,,text,Height,,Subject's height in cm,number,,,,,y,,,,,
head_circum,anthropometrics,,text,Head circumference,,Subject's head circumference in cm,number,,,,,,,,,,
tumor_hx,cancer_history_e72b,,yesno,Has this person had a tumor?,,,,,,,,y,,,,,
tumor_count,cancer_history_e72b,,dropdown,Tumor count total,"1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10",,autocomplete,,,,[tumor_hx] = '1',y,,,,,
sample_collected,labs,,yesno,Was a sample collected at this visit?,,,,,,,,y,,,,,
sample_type,labs,,checkbox,Sample type collected,"1, Buccal Swab/saliva | 2, K2EDTA (purple top) | 3, Cell Free DNA BCT (yellow/black top) | 4, Stool sample | 9998, Other",,,,,,[sample_collected] = '1',y,,,,,
other_sample_type,labs,,text,Please enter other sample type collected,,,,,,,[sample_type(9998)] = '1',y,,,,,
age_at_collection,labs,,text,Age at collection (in months),,,,,,,[sample_collected] = '1',,,,,, @READONLY
cps_name,patient_germline,,dropdown,CPS name,"1, Acute Lymphoblastic Leukemia Susceptibility - PAX5 | 2, ANKRD26-Related Thrombocytopenia and Leukemia Predisposition | 3, Ataxia Telangiectasia Syndrome | 4, Ataxia-Pancytopenia Syndrome | 5, Attenuated Familial Adenomatous Polyposis | 6, BAP1 Tumor Predisposition Syndrome | 7, Beckwith-Wiedemann Syndrome/Isolated Hemihyperplasia | 8, Birt-Hogg-Dube Syndrome | 9, Bloom Syndrome | 10, Bohring-Opitz Syndrome | 11, Carney Complex | 12, CBL Syndrome | 13, CDC73-Related Neoplastic Syndrome | 14, CDH1-Associated Breast Carcinoma Syndrome | 15, CEBPA-Related Leukemia Predisposition | 16, CHEK2-Associated Cancer Predisposition | 17, Congenital Amegakaryocytic Thrombocytopenia | 18, Constitutional Mismatch Repair Deficiency | 19, Costello Syndrome | 20, Cowden Syndrome | 21, DDX41-Related Leukemia Predisposition | 22, Diamond-Blackfan Anemia | 23, DICER1 Syndrome | 24, Dyskeratosis Congenita | 25, ETV6-Related Thrombocytopenia and Leukemia Predisposition | 26, Familial Adenomatous Polyposis | 27, Familial Gastrointestinal Stromal Tumor | 28, Familial Paraganglioma-Pheochromocytoma Syndrome | 29, Familial Platelet Disorder and AML Syndrome | 30, Fanconi Anemia | 31, GATA2 Deficiency | 32, Genetic Predisposition to Melanoma | 33, Genetic Predisposition to Meningioma | 34, Genetic Predisposition to Myofibromatosis | 35, Genetic Predisposition to Neuroblastoma | 36, Genetic Predisposition to Non-Syndromic Wilms Tumor | 37, Genetic Predisposition to Papillary Renal Cell Carcinoma | 38, Hepatolenticular Degeneration | 39, Hereditary Breast and Ovarian Cancer Syndrome | 40, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome | 41, Hereditary Retinoblastoma | 42, Juvenile Polyposis Syndrome | 43, Legius Syndrome | 44, LEOPARD Syndrome | 45, Li-Fraumeni Syndrome | 46, Lymphoproliferative Syndrome 1/ITK Deficiency | 47, Lynch Syndrome | 48, MIRAGE Syndrome | 49, Mosaic Variegated Aneuploidy Syndrome 1 | 50, Mulibrey Nanism | 51, Multiple Endocrine Neoplasia Type 1 | 52, Multiple Endocrine Neoplasia Type 2 | 53, Multiple Endocrine Neoplasia Type 4 | 54, MUTYH-Associated Polyposis | 55, Neurofibromatosis Type 1 | 56, Neurofibromatosis Type 2 | 57, Nevoid Basal Cell Carcinoma Syndrome | 58, Nijmegen Breakage Syndrome | 59, Noonan Syndrome | 60, Noonan Syndrome-Like Disorder with Loose Anagen Hair | 9997, Not reported | 61, Oculocutaneous Albinism | 9998, Other | 62, Perlman Syndrome | 63, Peutz-Jeghers Syndrome | 64, PIK3CA-Related Overgrowth Spectrum | 83, PTEN hamartoma tumor syndrome | 65, Radial Aplasia-Thrombocytopenia Syndrome | 66, Rhabdoid Tumor Predisposition Syndrome 1 | 67, Rhabdoid Tumor Predisposition Syndrome 2 | 68, Rothmund-Thompson Syndrome | 69, Rubinstein-Taybi Syndrome | 70, SAMD9L-Related Myelodysplastic Syndrome Predisposition | 71, Schinzel-Giedion Syndrome | 72, Schwannomatosis | 73, Shwachman-Diamond Syndrome | 74, Simpson-Golabi-Behmel Syndrome | 75, Sotos Syndrome | 76, Tuberous Sclerosis | 77, Tyrosinemia Type I | 78, Von Hippel-Lindau Syndrome | 79, Weaver Syndrome | 80, WT1 Syndromes | 81, Xeroderma Pigmentosum | 82, X-linked Lymphoproliferative Syndrome | 9999, Unknown",CPS diagnosis name,autocomplete,,,,,,,,,,
other_unknown_cps,patient_germline,,text,Please explain,,,,,,,[cps_name] = '9998' or [cps_name] = '9999',,,,,,
diagnosis_type,patient_germline,,radio,Type of diagnosis,"1, Molecular diagnosis | 2, Clinical diagnosis",The basis for diagnosis of the CPS,,,,,,,,,,,
diagnosis_age,patient_germline,,text,Age (in months),,,,,,,,,,,,, @READONLY
causative_germline_gene,patient_germline,,dropdown,Causative germline gene ,"1, ACD Gene | 2, ALK Gene | 3, ANKRD26 Gene | 4, APC Gene | 5, ASXL1 Gene | 6, ATM Gene | 7, ATP7B Gene | 8, BAP1 Gene | 9, BLM Gene | 10, BMPR1A Gene | 11, BRAF Gene | 12, BRCA1 Gene | 13, BRCA2 Gene | 14, BRIP1 Gene | 15, BUB1B Gene | 16, CBL Gene | 17, CDC73 Gene | 18, CDH1 Gene | 19, CDK4 Gene | 20, CDKN1B Gene | 21, CDKN1C Gene | 22, CDKN2A Gene | 23, CEBPA Gene | 24, CHEK2 Gene | 25, CREBBP Gene | 26, CTR9 Gene | 27, DDB2 Gene | 28, DDX41 Gene | 29, del(11p15.5) | 30, del(9p21) | 31, DICER1 Gene | 32, DIS3L2 Gene | 33, DKC1 Gene | 34, EP300 Gene | 35, EPCAM Gene | 36, ERCC2 Gene | 37, ERCC3 Gene | 38, ERCC4 Gene | 39, ERCC5 Gene | 40, ETV6 Gene | 41, EZH2 Gene | 42, FAH Gene | 43, FANCA Gene | 44, FANCB Gene | 45, FANCC Gene | 46, FANCD2 Gene | 47, FANCE Gene | 48, FANCF Gene | 49, FANCG Gene | 50, FANCI Gene | 51, FANCL Gene | 52, FANCM Gene | 53, FBXW7 Gene | 54, FH Gene | 55, FLCN Gene | 56, Gain of Chromosome 12q | 57, Gain of Chromosome 15q | 58, Gain of Chromosome 17q | 59, Gain of Chromosome 1q | 60, Gain of Chromosome 20q | 61, Gain of Chromosome 9q | 62, GATA2 Gene | 63, GPC3 Gene | 64, GPC4 Gene | 65, H19 Gene | 66, HRAS Gene | 67, IGF2 Gene | 68, ITK Gene | 69, KCNQ1OT1 Gene | 70, KDM3B Gene | 71, KIT Gene | 72, KRAS Gene | 73, Loss of Chromosome 13q | 74, Loss of Chromosome 14 | 75, Loss of Chromosome 1p | 76, Loss of Chromosome 22 | 77, Loss of Chromosome 3p | 78, Loss of Chromosome Y | 79, LZTR1 Gene | 80, MAP2K1 Gene | 81, MAPK1 Gene | 82, MAX Gene | 83, MEN1 Gene | 84, MET Gene | 85, MLH1 Gene | 86, Monosomy 7 | 87, MPL Gene | 88, MRAS Gene | 89, MSH2 Gene | 90, MSH6 Gene | 91, MUTYH Gene | 92, NBN Gene | 93, NF1 Gene | 94, NF2 Gene | 95, NHP2 Gene | 96, NOP10 Gene | 97, NOTCH3 Gene | 98, NRAS Gene | 99, NSD1 Gene | 100, NTRK1 Gene | 101, NYNRIN Gene | 102, OCA2 Gene | 103, OCA5 Gene | 104, OFD1 Gene | 105, PALB2 Gene | 106, PARN Gene | 107, PAX5 Gene | 108, PDGFRA Gene | 109, PDGFRB Gene | 110, PHOX2B Gene | 111, PIK3CA Gene | 112, PMS2 Gene | 113, POLH Gene | 114, PPP1CB Gene | 115, PRKAR1A Gene | 116, PTCH1 Gene | 117, PTEN Gene | 118, PTPN11 Gene | 119, RAD51C Gene | 120, RAF1 Gene | 121, RASA2 Gene | 122, RB1 Gene | 123, RBM8A Gene | 124, RECQL4 Gene | 125, REST Gene | 126, RET Gene | 127, RIT1 Gene | 128, RPL11 Gene | 129, RPL19 Gene | 130, RPL26 Gene | 131, RPL35A Gene | 132, RPL5 Gene | 133, RPS10 Gene | 134, RPS17 Gene | 135, RPS19 Gene | 136, RPS24 Gene | 137, RPS26 Gene | 138, RPS7 Gene | 139, RRAS Gene | 140, RRAS2 Gene | 141, RTEL1 Gene | 142, RUNX1 Gene | 143, SAMD9 Gene | 144, SAMD9L Gene | 145, SBDS Gene | 146, SDHA Gene | 147, SDHAF2 Gene | 148, SDHB Gene | 149, SDHC Gene | 150, SDHD Gene | 151, SETBP1 Gene | 152, SH2D1A Gene | 153, SHOC2 Gene | 154, SLC24A5 Gene | 155, SLC45A2 Gene | 156, SMAD4 Gene | 157, SMARCA4 Gene | 158, SMARCB1 Gene | 159, SMARCE1 Gene | 160, SOS1 Gene | 161, SOS2 Gene | 162, SPRED1 Gene | 163, STK11 Gene | 164, SUFU Gene | 165, TERC Gene | 166, TERT Gene | 167, TINF2 Gene | 168, TMEM127 Gene | 169, TP53 Gene | 170, TRIM28 Gene | 171, TRIM37 Gene | 172, Trisomy 17 | 173, Trisomy 7 | 174, TSC1 Gene | 175, TSC2 Gene | 176, TYR Gene | 177, TYRP1 Gene | 178, VHL Gene | 179, WRAP53 Gene | 180, WT1 Gene | 181, XIAP Gene | 182, XPA Gene | 183, XPC Gene | 9998, Gene not listed | 9999, Unknown",The germline variant responsible for the CPS diagnosis ,autocomplete,,,,,,,,,,
causative_germline_unknown,patient_germline,,text,Please explain your response,,,,,,,[causative_germline_gene] = '9999',,,,,,
oth_causative_germline_gene,patient_germline,,text,Other causative germline gene ,,Specify other causative germline gene,,,,,[causative_germline_gene] = '9998',,,,,,
inherittance_pattern,variant_data,,dropdown,Inheritance pattern,"1, Autosomal Dominant | 2, Autosomal Recessive | 3, X-Linked Dominant | 4, X-Linked Recessive",,autocomplete,,,,,,,,,,
variant_interp,variant_data,,dropdown,Variant interpretation (from report),"1, P | 2, LP | 3, VUS | 4, LB | 5, B | 9998, Other",,autocomplete,,,,,,,,,,
other_variant_interp,variant_data,,text,Other variant interpretation ,,,,,,,[variant_interp] = '9998',,,,,,
transcript,variant_data,,text,Transcript,,,,,,,,,,,,,
cdna_nomenclature,variant_data,,text,cDNA nomenclature,,,,,,,,,,,,,
protein_nomenclature,variant_data,,text,Protein nomenclature,,,,,,,,,,,,,
zygosity,variant_data,,dropdown,Zygosity,"1, Heterozygous | 2, Homozygous | 3, Compound heterozygous | 4, Hemizygous | 5, Mosaic | 9999, Unknown/Not specified",,autocomplete,,,,,,,,,,
clin_allele_registry_id,variant_data,,text,Clingen Allele Registry ID ,,,,,,,,,,,,,
parental_status,variant_data,,dropdown,Parental status,"1, Maternally inherited | 2, Paternally inherited | 3, De novo | 4, Mosaic | 9999, Unknown/Not tested",,autocomplete,,,,,,,,,,
variant_effect,variant_data,,dropdown,Variant effect,"1, Missense | 2, Nonsense | 3, Frameshift | 4, Intronic variant | 5, Splice Site | 6, Splice Region | 7, Splice Donor | 8, Splice Acceptor | 9, Synonymous | 10, Inframe Insertion | 11, Inframe Deletion | 12, Stop Gained | 13, Stop Lost | 14, Start Lost | 15, 5' UTR | 9998, Other",,autocomplete,,,,,,,,,,
gnomad_presence,variant_data,,yesno,Present in GnomAD?,,,,,,,,,,,,,
gnomad_allele_count,variant_data,,text,GnomAD allele count ,,,number,,,,[gnomad_presence]='1',,,,,,
gnomad_total_alleles,variant_data,,text,GnomAD total alleles ,,,number,,,,[gnomad_presence]='1',,,,,,
gnomad_allele_frequency,variant_data,,calc,GnomAD allele frequency ,([gnomad_allele_count]/[gnomad_total_alleles]),,,,,,[gnomad_presence]='1',,,,,,
clinvar_presence,variant_data,,yesno,Present in ClinVar?,,,,,,,,,,,,,
clinvar_variant,variant_data,,checkbox,ClinVar variant classification,"1, P {clinvar_variant_p} | 2, LP {clinvar_variant_lp} | 3, VUS {clinvar_variant_vus} | 4, LB {clinvar_variant_lb} | 5, B {clinvar_variant_b}",,,,,,"[clinvar_presence]=""1""",,,,,,
clingen_panel,variant_data,,dropdown,ClinGen expert panel classification,"1, P | 2, LP | 3, VUS | 4, LB | 5, B | 6, Not reviewed by expert panel",,autocomplete,,,,"[clinvar_presence]=""1""",,,,,,
clinvar_variant_p,variant_data,,text,ClinVar variant P,,,number,,,,[clinvar_variant(1)] = '1',,,,,,
clinvar_variant_lp,variant_data,,text,ClinVar variant LP,,,number,,,,[clinvar_variant(2)] = '1',,,,,,
clinvar_variant_vus,variant_data,,text,ClinVar variant VUS,,,number,,,,[clinvar_variant(3)] = '1',,,,,,
clinvar_variant_lb,variant_data,,text,ClinVar variant LB,,,number,,,,[clinvar_variant(4)] = '1',,,,,,
clinvar_variant_b,variant_data,,text,ClinVar variant B,,,number,,,,[clinvar_variant(5)] = '1',,,,,,
cosmic_presence,variant_data,,yesno,Present in COSMIC?,,,,,,,,,,,,,
tumor_diagnosis,cancer_history_details,,text,Tumor diagnosis,,Final diagnosis as written on the pathology report,,,,,,,,,,,
tumor_diag_morphology,cancer_history_details,,dropdown,Tumor diagnosis morphology,"2, 8000/0 Neoplasm, benign | 3, 8000/0 Tumor, benign | 4, 8000/0 Unclassified tumor, benign | 5, 8000/1 Neoplasm, uncertain whether benign or malignant | 6, 8000/1 Neoplasm, NOS | 7, 8000/1 Tumor, NOS | 8, 8000/1 Unclassified tumor, borderline malignancy | 9, 8000/1 Unclassified tumor, uncertain whether benign or malignant | 10, 8000/3 Neoplasm, malignant | 11, 8000/3 Blastoma, NOS | 12, 8000/3 Tumor, malignant, NOS | 13, 8000/3 Cancer | 14, 8000/3 Malignancy | 15, 8000/3 Unclassified tumor, malignant | 16, 8000/6 Neoplasm, metastatic | 17, 8000/6 Neoplasm, secondary | 18, 8000/6 Tumor embolus | 19, 8000/6 Tumor, metastatic | 20, 8000/6 Tumor, secondary | 21, 8000/9 Neoplasm, malignant, uncertain whether primary or metastatic | 22, 8000/9 Unclassified tumor, malignant, uncertain whether primary or metastatic | 23, 8001/0 Tumor cells, benign | 24, 8001/1 Tumor cells, uncertain whether benign or malignant | 25, 8001/1 Tumor cells, NOS | 26, 8001/3 Tumor cells, malignant | 27, 8002/3 Malignant tumor, small cell type | 28, 8003/3 Malignant tumor, giant cell type | 29, 8004/3 Malignant tumor, spindle cell type | 30, 8004/3 Malignant tumor, fusiform cell type | 31, 8005/0 Clear cell tumor, NOS | 32, 8005/3 Malignant tumor, clear cell type | 34, 8010/0 Epithelial tumor, benign | 35, 8010/2 Carcinoma in situ, NOS | 36, 8010/2 Intraepithelial carcinoma, NOS | 37, 8010/3 Carcinoma, NOS | 38, 8010/3 Epithelial tumor, malignant | 39, 8010/3 Heterotopia-associated carcinoma | 40, 8010/6 Carcinoma, metastatic, NOS | 41, 8010/6 Secondary carcinoma | 42, 8010/9 Carcinomatosis | 43, 8011/0 Epithelioma, benign | 44, 8011/3 Epithelioma, malignant | 45, 8011/3 Epithelioma, NOS | 46, 8012/3 Large cell carcinoma, NOS | 47, 8013/3 Large cell neuroendocrine carcinoma | 48, 8013/3 Combined large cell neuroendocrine carcinoma | 49, 8014/3 Large cell carcinoma with rhabdoid phenotype | 50, 8015/3 Glassy cell carcinoma | 51, 8020/3 Carcinoma, undifferentiated, NOS | 52, 8020/3 Carcinoma, poorly differentiated, NOS | 53, 8020/3 Anaplastic undifferentiated carcinoma | 54, 8020/3 Dedifferentiated carcinoma | 55, 8021/3 Carcinoma, anaplastic, NOS | 56, 8022/3 Pleomorphic carcinoma | 57, 8023/3 Nuclear protein in testis (NUT)-associated carcinoma | 58, 8023/3 NUT carcinoma | 59, 8023/3 NUT midline carcinoma | 60, 8030/3 Giant cell and spindle cell carcinoma | 61, 8031/3 Giant cell carcinoma | 62, 8032/3 Spindle cell carcinoma, NOS | 63, 8033/3 Pseudosarcomatous carcinoma | 64, 8033/3 Sarcomatoid carcinoma | 65, 8034/3 Polygonal cell carcinoma | 66, 8035/3 Carcinoma with osteoclast-like giant cells | 67, 8035/3 Squamous carcinoma with osteoclast-like giant cells | 68, 8035/3 Undifferentiated carcinoma with osteoclast-like giant cells | 69, 8040/0 Tumorlet, benign | 70, 8040/0 Diffuse idiopathic neuroendocrine cell hyperplasia | 71, 8040/1 Tumorlet, NOS | 72, 8041/3 Small cell carcinoma, NOS | 73, 8041/3 Reserve cell carcinoma | 74, 8041/3 Round cell carcinoma | 75, 8041/3 Small cell neuroendocrine carcinoma | 76, 8041/3 Small cell carcinoma, pulmonary type | 77, 8042/3 Oat cell carcinoma | 78, 8043/3 Small cell carcinoma, fusiform cell | 79, 8044/3 Small cell carcinoma, intermediate cell | 80, 8044/3 Small cell carcinoma, hypercalcemic type | 81, 8045/3 Combined small cell carcinoma | 82, 8045/3 Mixed small cell carcinoma | 83, 8045/3 Combined small cell-adenocarcinoma | 84, 8045/3 Combined small cell-large cell carcinoma | 85, 8045/3 Combined small cell-squamous cell carcinoma | 86, 8046/3 Non-small cell carcinoma | 88, 8050/0 Papilloma, NOS | 89, 8050/2 Papillary carcinoma in situ, NOS | 90, 8050/3 Papillary carcinoma, NOS | 91, 8051/0 Verrucous papilloma | 92, 8051/3 Verrucous carcinoma, NOS | 93, 8051/3 Verrucous epidermoid carcinoma | 94, 8051/3 Verrucous squamous cell carcinoma | 95, 8052/0 Squamous cell papilloma, NOS | 96, 8052/0 Keratotic papilloma | 97, 8052/0 Squamous papilloma | 98, 8052/0 Benign keratosis, NOS | 99, 8052/0 Seborrhoeic keratosis | 100, 8052/0 Solar lentigo | 101, 8052/0 Lichen planus-like keratosis | 102, 8052/2 Papillary squamous cell carcinoma, non-invasive | 103, 8052/2 Papillary squamous cell carcinoma in situ | 104, 8052/3 Papillary squamous cell carcinoma | 105, 8052/3 Papillary epidermoid carcinoma | 106, 8053/0 Squamous cell papilloma, inverted | 107, 8054/0 Warty dyskeratoma | 108, 8054/3 Warty carcinoma | 109, 8054/3 Condylomatous carcinoma | 110, 8054/3 Warty-basaloid carcinoma | 111, 8060/0 Squamous papillomatosis | 112, 8060/0 Papillomatosis, NOS | 113, 8070/0 Actinic keratosis | 114, 8070/0 Arsenical keratosis | 115, 8070/0 PUVA keratosis | 116, 8070/2 Squamous cell carcinoma in situ, NOS | 117, 8070/2 Epidermoid carcinoma in situ, NOS | 118, 8070/2 Intraepidermal carcinoma, NOS | 119, 8070/2 Intraepithelial squamous cell carcinoma | 120, 8070/3 Squamous cell carcinoma, NOS | 121, 8070/3 Squamous cell carcinoma, usual type | 122, 8070/3 Epidermoid carcinoma, NOS | 123, 8070/3 Squamous carcinoma | 124, 8070/3 Squamous cell epithelioma | 125, 8070/6 Squamous cell carcinoma, metastatic, NOS | 126, 8071/2 Differentiated intraepithelial neoplasia | 127, 8071/2 Differentiated penile intraepithelial neoplasia (PeIN) | 128, 8071/2 Differentiated vulvar intraepithelial neoplasia (VIN) | 129, 8071/3 Squamous cell carcinoma, keratinizing, NOS | 130, 8071/3 Epidermoid carcinoma, keratinizing | 131, 8071/3 Squamous cell carcinoma, large cell, keratinizing | 132, 8071/3 Keratoacanthoma | 133, 8072/0 Large cell acanthoma | 134, 8072/3 Squamous cell carcinoma, large cell, nonkeratinizing, NOS | 135, 8072/3 Epidermoid carcinoma, large cell, nonkeratinizing | 136, 8072/3 Squamous cell carcinoma, nonkeratinizing, NOS | 137, 8073/3 Squamous cell carcinoma, small cell, nonkeratinizing | 138, 8073/3 Epidermoid carcinoma, small cell, nonkeratinizing | 139, 8074/3 Squamous cell carcinoma, spindle cell | 140, 8074/3 Epidermoid carcinoma, spindle cell | 141, 8074/3 Squamous cell carcinoma, sarcomatoid | 142, 8074/3 Pseudovascular squamous cell carcinoma | 143, 8075/3 Squamous cell carcinoma, adenoid | 144, 8075/3 Squamous cell carcinoma, acantholytic | 145, 8075/3 Squamous cell carcinoma, pseudoglandular | 146, 8076/2 Squamous cell carcinoma in situ with questionable stromal invasion | 147, 8076/2 Epidermoid carcinoma in situ with questionable stromal invasion | 148, 8076/3 Squamous cell carcinoma, microinvasive | 149, 8077/0 Squamous intraepithelial neoplasia, low grade | 150, 8077/0 Squamous intraepithelial neoplasia, grade I | 151, 8077/0 Low grade squamous intraepithelial lesion | 152, 8077/0 Anal intraepithelial neoplasia, low grade | 153, 8077/0 Cervical intraepithelial neoplasia, low grade | 154, 8077/0 Esophageal squamous intraepithelial neoplasia (dysplasia), low grade | 155, 8077/2 Squamous intraepithelial neoplasia, high grade | 156, 8077/2 Squamous intraepithelial neoplasia, grade II | 157, 8077/2 Squamous intraepithelial neoplasia, grade III | 158, 8077/2 Squamous dysplasia, high grade | 159, 8077/2 High grade squamous intraepithelial lesion | 160, 8077/2 Anal intraepithelial neoplasia, grade III | 161, 8077/2 AIN III | 162, 8077/2 Cervical intraepithelial neoplasia, grade III | 163, 8077/2 CIN III, NOS | 164, 8077/2 CIN III with severe dysplasia | 165, 8077/2 Esophageal squamous intraepithelial neoplasia (dysplasia), high grade | 166, 8077/2 Vaginal intraepithelial neoplasia, grade III | 167, 8077/2 VAIN III | 168, 8077/2 Vulvar intraepithelial neoplasia, grade III | 169, 8077/2 VIN III | 170, 8078/3 Squamous cell carcinoma with horn formation | 171, 8080/2 Queyrat erythroplasia | 172, 8081/2 Bowen disease | 173, 8081/2 Intraepidermal squamous cell carcinoma, Bowen type | 174, 8082/3 Lymphoepithelial carcinoma | 175, 8082/3 Lymphoepithelioma | 176, 8082/3 Lymphoepithelioma-like carcinoma | 177, 8082/3 Schmincke tumor | 178, 8083/3 Basaloid squamous cell carcinoma | 179, 8083/3 Papillary-basaloid carcinoma | 180, 8084/0 Clear cell acanthoma | 181, 8084/3 Squamous cell carcinoma, clear cell type | 182, 8085/3 Squamous cell carcinoma, HPV positive | 183, 8086/3 Squamous cell carcinoma, HPV negative | 185, 8090/1 Basal cell tumor | 186, 8090/3 Basal cell carcinoma, NOS | 187, 8090/3 Basal cell epithelioma | 188, 8090/3 Rodent ulcer | 189, 8090/3 Pigmented basal cell carcinoma | 190, 8090/3 Basal cell carcinoma with adnexal differentiation | 191, 8091/3 Superficial basal cell carcinoma | 192, 8091/3 Multifocal superficial basal cell carcinoma | 193, 8091/3 Multicentric basal cell carcinoma | 194, 8092/3 Infiltrating basal cell carcinoma, NOS | 195, 8092/3 Infiltrating basal cell carcinoma, non-sclerosing | 196, 8092/3 Infiltrating basal cell carcinoma, sclerosing | 197, 8092/3 Basal cell carcinoma, desmoplastic type | 198, 8092/3 Basal cell carcinoma, morpheic | 199, 8092/3 Basal cell carcinoma, sarcomatoid | 200, 8093/3 Basal cell carcinoma, fibroepithelial | 201, 8093/3 Fibroepithelioma, NOS | 202, 8093/3 Fibroepithelioma of Pinkus type | 203, 8093/3 Fibroepithelial basal cell carcinoma, Pinkus type | 204, 8093/3 Pinkus tumor | 205, 8094/3 Basosquamous carcinoma | 206, 8094/3 Mixed basal-squamous cell carcinoma | 207, 8095/3 Metatypical carcinoma | 208, 8096/0 Intraepidermal epithelioma of Jadassohn | 209, 8097/3 Basal cell carcinoma, nodular | 210, 8097/3 Basal cell carcinoma, micronodular | 211, 8098/3 Adenoid basal carcinoma | 212, 8100/0 Trichoepithelioma | 213, 8100/0 Brooke tumor | 214, 8100/0 Epithelioma adenoides cysticum | 215, 8100/0 Trichoblastoma | 216, 8100/0 Trichogerminoma | 217, 8100/3 Trichoblastic carcinoma | 218, 8100/3 Trichoblastic carcinosarcoma | 219, 8101/0 Trichofolliculoma | 220, 8102/0 Trichilemmoma | 221, 8102/3 Trichilemmocarcinoma | 222, 8102/3 Trichilemmal carcinoma | 223, 8103/0 Pilar tumor | 224, 8103/1 Proliferating trichilemmal cyst | 225, 8103/1 Proliferating trichilemmal tumor | 226, 8104/0 Pilar sheath acanthoma | 227, 8104/0 Tumor of follicular infundibulum | 228, 8110/0 Pilomatricoma, NOS | 229, 8110/0 Pilomatrixoma, NOS | 230, 8110/0 Calcifying epithelioma of Malherbe | 231, 8110/0 Melanocytic matricoma | 232, 8110/3 Pilomatrical carcinoma | 233, 8110/3 Pilomatrix carcinoma | 234, 8110/3 Matrical carcinoma | 235, 8110/3 Pilomatricoma, malignant | 236, 8110/3 Pilomatrixoma, malignant | 238, 8120/0 Urothelial papilloma, NOS | 239, 8120/0 Transitional cell papilloma, benign | 240, 8120/0 Transitional papilloma | 241, 8120/0 Transitional cell papilloma, NOS | 242, 8120/0 Papilloma of bladder | 243, 8120/2 Urothelial carcinoma in situ | 244, 8120/2 Transitional cell carcinoma in situ | 245, 8120/3 Transitional cell carcinoma, NOS | 246, 8120/3 Urothelial carcinoma, NOS | 247, 8120/3 Transitional carcinoma | 248, 8120/3 Squamotransitional carcinoma | 249, 8121/0 Sinonasal papilloma, exophytic | 250, 8121/0 Schneiderian papilloma, NOS | 251, 8121/0 Sinonasal papilloma, NOS | 252, 8121/0 Sinonasal papilloma, fungiform | 253, 8121/0 Urothelial papilloma, inverted | 254, 8121/0 Transitional papilloma, inverted, NOS | 255, 8121/0 Transitional cell papilloma, inverted, NOS | 256, 8121/1 Sinonasal papilloma, inverted | 257, 8121/1 Columnar cell papilloma | 258, 8121/1 Cylindrical cell papilloma | 259, 8121/1 Schneiderian papilloma, oncocytic | 260, 8121/1 Schneiderian papilloma, inverted | 261, 8121/1 Sinonasal papilloma, oncocytic | 262, 8121/3 Schneiderian carcinoma | 263, 8121/3 Cylindrical cell carcinoma | 264, 8122/3 Urothelial carcinoma, sarcomatoid | 265, 8122/3 Urothelial carcinoma, spindle cell | 266, 8122/3 Transitional cell carcinoma, spindle cell | 267, 8122/3 Transitional cell carcinoma, sarcomatoid | 268, 8123/3 Basaloid carcinoma | 269, 8124/3 Cloacogenic carcinoma | 270, 8130/1 Papillary urothelial neoplasm of low malignant potential | 271, 8130/1 Papillary transitional cell neoplasm of low malignant potential | 272, 8130/2 Papillary urothelial carcinoma, non-invasive | 273, 8130/2 Papillary transitional cell carcinoma, non-invasive | 274, 8130/3 Papillary urothelial carcinoma | 275, 8130/3 Papillary transitional cell carcinoma | 276, 8131/3 Urothelial carcinoma, micropapillary | 277, 8131/3 Transitional cell carcinoma, micropapillary | 279, 8140/0 Adenoma, NOS | 280, 8140/1 Atypical adenoma | 281, 8140/1 Bronchial adenoma, NOS | 282, 8140/2 Adenocarcinoma in situ, NOS | 283, 8140/3 Adenocarcinoma, NOS | 284, 8140/3 Adenocarcinoma, usual type | 285, 8140/3 Carcinoma of Skene, Cowper and Littre glands | 286, 8140/3 Endolymphatic sac tumor | 287, 8140/3 Parathyroid carcinoma | 288, 8140/3 Acinar adenocarcinoma of prostate | 289, 8140/6 Adenocarcinoma, metastatic, NOS | 290, 8141/3 Scirrhous adenocarcinoma | 291, 8141/3 Carcinoma with productive fibrosis | 292, 8141/3 Scirrhous carcinoma | 293, 8142/3 Linitis plastica | 294, 8143/3 Superficial spreading adenocarcinoma | 295, 8144/0 Adenoma, intestinal type | 296, 8144/3 Adenocarcinoma, intestinal type | 297, 8144/3 Adenocarcinoma, enteric | 298, 8144/3 Carcinoma, intestinal type | 299, 8144/3 Mucinous carcinoma, intestinal type | 300, 8145/3 Carcinoma, diffuse type | 301, 8145/3 Adenocarcinoma, diffuse type | 302, 8146/0 Monomorphic adenoma | 303, 8147/0 Basal cell adenoma | 304, 8147/3 Basal cell adenocarcinoma | 305, 8147/3 Basal cell carcinoma of prostate | 306, 8148/0 Glandular intraepithelial neoplasia, low grade | 307, 8148/0 Glandular intraepithelial neoplasia, grade I | 308, 8148/0 Glandular intraepithelial neoplasia, grade II | 309, 8148/0 Biliary intraepithelial neoplasia, low grade | 310, 8148/0 Esophageal glandular dysplasia (intraepithelial neoplasia), low grade | 311, 8148/2 Glandular intraepithelial neoplasia, high grade | 312, 8148/2 Glandular intraepithelial neoplasia, grade III | 313, 8148/2 Flat intraepithelial neoplasia, high grade | 314, 8148/2 Biliary intraepithelial neoplasia, high grade | 315, 8148/2 Biliary intraepithelial neoplasia, grade 3 (BilIN-3) | 316, 8148/2 Esophageal glandular dysplasia (intraepithelial neoplasia), high grade | 317, 8148/2 Esophageal intraepithelial neoplasia, high grade | 318, 8148/2 Prostatic intraepithelial neoplasia, grade III | 319, 8148/2 PIN III | 320, 8148/2 Prostatic intraepithelial neoplasia, high grade | 321, 8149/0 Canalicular adenoma | 322, 8150/0 Pancreatic neuroendocrine microadenoma | 323, 8150/0 Pancreatic endocrine tumor, benign | 324, 8150/0 Islet cell tumor, benign | 325, 8150/0 Pancreatic microadenoma | 326, 8150/3 Pancreatic neuroendocrine tumor, nonfunctioning | 327, 8150/3 Pancreatic endocrine tumor, nonfunctioning | 328, 8150/3 Pancreatic endocrine tumor, NOS | 329, 8150/3 Islet cell adenoma | 330, 8150/3 Islet cell adenomatosis | 331, 8150/3 Nesidioblastoma | 332, 8150/3 Islet cell tumor, NOS | 333, 8150/3 Islet cell adenocarcinoma | 334, 8150/3 Islet cell carcinoma | 335, 8151/3 Insulinoma, NOS | 336, 8151/3 Beta cell adenoma | 337, 8151/3 Beta cell tumor | 338, 8152/3 Glucagonoma | 339, 8152/3 Alpha cell tumor | 340, 8152/3 Enteroglucagonoma | 341, 8152/3 Glucagon-like peptide-producing tumor | 342, 8152/3 L-cell tumor | 343, 8152/3 Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor | 344, 8152/3 PP/PYY producing tumor | 345, 8153/3 Gastrinoma | 346, 8153/3 G cell tumor | 347, 8153/3 Gastrin cell tumor | 348, 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) | 349, 8154/3 Mixed pancreatic endocrine and exocrine tumor, malignant | 350, 8154/3 Mixed islet cell and exocrine adenocarcinoma | 351, 8154/3 Mixed acinar-endocrine carcinoma | 352, 8154/3 Mixed acinar-neuroendocrine carcinoma | 353, 8154/3 Mixed acinar-endocrine-ductal carcinoma | 354, 8154/3 Mixed ductal-endocrine carcinoma | 355, 8154/3 Mixed ductal-neuroendocrine carcinoma | 356, 8154/3 Mixed endocrine and exocrine adenocarcinoma | 357, 8155/3 Vipoma | 358, 8156/3 Somatostatinoma | 359, 8156/3 Somatostatin cell tumor | 360, 8158/3 ACTH-producing tumor | 361, 8158/3 Endocrine tumor, functioning, NOS | 362, 8160/0 Bile duct adenoma | 363, 8160/0 Cholangioma | 364, 8160/3 Cholangiocarcinoma | 365, 8160/3 Bile duct adenocarcinoma | 366, 8160/3 Bile duct carcinoma | 367, 8161/0 Bile duct cystadenoma | 368, 8161/3 Bile duct cystadenocarcinoma | 369, 8162/3 Perihilar cholangiocarcinoma | 370, 8162/3 Klatskin tumor | 371, 8163/0 Pancreatobiliary neoplasm, non-invasive | 372, 8163/0 Non-invasive pancreatobiliary papillary neoplasm with low grade dysplasia | 373, 8163/0 Non-invasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia | 374, 8163/2 Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia | 375, 8163/2 Non-invasive pancreatobiliary papillary neoplasm with high grade dysplasia | 376, 8163/2 Non-invasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia | 377, 8163/3 Pancreatobiliary type carcinoma | 378, 8163/3 Adenocarcinoma, pancreatobiliary type | 379, 8170/0 Liver cell adenoma | 380, 8170/0 Hepatocellular adenoma | 381, 8170/0 Hepatoma, benign | 382, 8170/3 Hepatocellular carcinoma, NOS | 383, 8170/3 Hepatoma, NOS | 384, 8170/3 Hepatocarcinoma | 385, 8170/3 Hepatoma, malignant | 386, 8170/3 Liver cell carcinoma | 387, 8171/3 Hepatocellular carcinoma, fibrolamellar | 388, 8172/3 Hepatocellular carcinoma, scirrhous | 389, 8172/3 Sclerosing hepatic carcinoma | 390, 8173/3 Hepatocellular carcinoma, spindle cell variant | 391, 8173/3 Hepatocellular carcinoma, sarcomatoid | 392, 8174/3 Hepatocellular carcinoma, clear cell type | 393, 8175/3 Hepatocellular carcinoma, pleomorphic type | 394, 8180/3 Combined hepatocellular carcinoma and cholangiocarcinoma | 395, 8180/3 Hepatocholangiocarcinoma | 396, 8180/3 Mixed hepatocellular and bile duct carcinoma | 397, 8190/0 Trabecular adenoma | 398, 8190/3 Trabecular adenocarcinoma | 399, 8190/3 Trabecular carcinoma | 400, 8191/0 Embryonal adenoma | 401, 8200/0 Eccrine dermal cylindroma | 402, 8200/0 Cylindroma of skin | 403, 8200/0 Cylindroma of breast | 404, 8200/0 Turban tumor | 405, 8200/3 Adenoid cystic carcinoma | 406, 8200/3 Cylindroma, NOS | 407, 8200/3 Adenocarcinoma, cylindroid | 408, 8200/3 Adenocystic carcinoma | 409, 8200/3 Bronchial adenoma, cylindroid | 410, 8200/3 Thymic carcinoma with adenoid cystic carcinoma-like features | 411, 8201/2 Cribriform carcinoma in situ | 412, 8201/2 Ductal carcinoma in situ, cribriform type | 413, 8201/3 Cribriform carcinoma, NOS | 414, 8201/3 Ductal carcinoma, cribriform type | 415, 8201/3 Cribriform comedo type carcinoma | 416, 8201/3 Adenocarcinoma, cribriform comedo type | 417, 8202/0 Microcystic adenoma | 418, 8204/0 Lactating adenoma | 419, 8210/0 Adenomatous polyp, NOS | 420, 8210/0 Polypoid adenoma | 421, 8210/2 Adenocarcinoma in situ in adenomatous polyp | 422, 8210/2 Adenocarcinoma in situ in polyp, NOS | 423, 8210/2 Carcinoma in situ in polyp, NOS | 424, 8210/2 Adenocarcinoma in situ in polypoid adenoma | 425, 8210/2 Adenocarcinoma in situ in tubular adenoma | 426, 8210/2 Carcinoma in situ in adenomatous polyp | 427, 8210/3 Adenocarcinoma in adenomatous polyp | 428, 8210/3 Adenocarcinoma in polyp, NOS | 429, 8210/3 Carcinoma in polyp, NOS | 430, 8210/3 Adenocarcinoma in polypoid adenoma | 431, 8210/3 Adenocarcinoma in tubular adenoma | 432, 8210/3 Carcinoma in adenomatous polyp | 433, 8211/0 Tubular adenoma, NOS | 434, 8211/3 Tubular adenocarcinoma | 435, 8211/3 Tubular carcinoma | 436, 8212/0 Flat adenoma | 437, 8213/0 Serrated adenoma, NOS | 438, 8213/0 Traditional serrated adenoma | 439, 8213/0 Mixed adenomatous and hyperplastic polyp | 440, 8213/0 Sessile serrated adenoma, NOS | 441, 8213/0 Sessile serrated polyp | 442, 8213/0 Traditional sessile serrated adenoma | 443, 8213/3 Serrated adenocarcinoma | 444, 8214/3 Parietal cell carcinoma | 445, 8214/3 Parietal cell adenocarcinoma | 446, 8215/3 Adenocarcinoma of anal glands | 447, 8215/3 Adenocarcinoma of anal ducts | 448, 8220/0 Adenomatous polyposis coli | 449, 8220/0 Adenomatosis, NOS | 450, 8220/0 Familial polyposis coli | 451, 8220/3 Adenocarcinoma in adenomatous polyposis coli | 452, 8221/0 Multiple adenomatous polyps | 453, 8221/3 Adenocarcinoma in multiple adenomatous polyps | 454, 8230/2 Ductal carcinoma in situ, solid type | 455, 8230/2 Intraductal carcinoma, solid type | 456, 8230/3 Solid carcinoma, NOS | 457, 8230/3 Solid adenocarcinoma, NOS | 458, 8230/3 Solid carcinoma with mucin formation | 459, 8230/3 Solid adenocarcinoma with mucin formation | 460, 8231/3 Carcinoma simplex | 461, 8240/3 Neuroendocrine tumor, NOS | 462, 8240/3 Carcinoid tumor, NOS | 463, 8240/3 Carcinoid, NOS | 464, 8240/3 Bronchial adenoma, carcinoid | 465, 8240/3 Neuroendocrine carcinoma, low grade | 466, 8240/3 Neuroendocrine carcinoma, well differentiated | 467, 8240/3 Neuroendocrine tumor, grade 1 | 468, 8240/3 Typical carcinoid | 469, 8241/3 Enterochromaffin cell carcinoid | 470, 8241/3 Argentaffinoma | 471, 8241/3 Carcinoid tumor, argentaffin | 472, 8241/3 EC cell carcinoid | 473, 8241/3 Serotonin producing carcinoid | 474, 8241/3 Serotonin producing tumor | 475, 8242/3 Enterochromaffin-like cell tumor | 476, 8242/3 ECL cell carcinoid | 477, 8243/3 Goblet cell carcinoid | 478, 8243/3 Mucinous carcinoid | 479, 8243/3 Mucocarcinoid tumor | 480, 8244/3 Mixed adenoneuroendocrine carcinoma | 481, 8244/3 Combined carcinoid and adenocarcinoma | 482, 8244/3 Mixed carcinoid and adenocarcinoma | 483, 8244/3 Composite carcinoid | 484, 8244/3 MANEC | 485, 8244/3 Mixed carcinoid-adenocarcinoma | 486, 8245/1 Tubular carcinoid | 487, 8245/3 Adenocarcinoid tumor | 488, 8246/3 Neuroendocrine carcinoma, NOS | 489, 8246/3 Poorly differentiated neuroendocrine neoplasm | 490, 8247/3 Merkel cell carcinoma | 491, 8247/3 Merkel cell tumor | 492, 8247/3 Primary cutaneous neuroendocrine carcinoma | 493, 8248/1 Apudoma | 494, 8249/3 Neuroendocrine tumor, grade 2 | 495, 8249/3 Atypical carcinoid tumor | 496, 8249/3 Neuroendocrine carcinoma, moderately differentiated | 497, 8249/3 Neuroendocrine tumor, grade 3 | 498, 8250/0 Atypical adenomatous hyperplasia | 499, 8250/1 Pulmonary adenomatosis | 500, 8250/2 Adenocarcinoma in situ of lung, non-mucinous | 501, 8250/3 Lepidic adenocarcinoma | 502, 8250/3 Bronchiolo-alveolar adenocarcinoma, NOS | 503, 8250/3 Bronchiolo-alveolar carcinoma, NOS | 504, 8250/3 Alveolar cell carcinoma | 505, 8250/3 Bronchiolar adenocarcinoma | 506, 8250/3 Bronchiolar carcinoma | 507, 8251/0 Alveolar adenoma | 508, 8251/3 Alveolar adenocarcinoma | 509, 8251/3 Alveolar carcinoma | 510, 8252/3 Bronchiolo-alveolar carcinoma, non-mucinous | 511, 8252/3 Bronchiolo-alveolar carcinoma, Clara cell | 512, 8252/3 Bronchiolo-alveolar carcinoma, type II pneumocyte | 513, 8253/2 Adenocarcinoma in situ of lung, mucinous | 514, 8253/3 Adenocarcinoma of lung, mucinous | 515, 8253/3 Bronchiolo-alveolar carcinoma, mucinous | 516, 8253/3 Bronchiolo-alveolar carcinoma, goblet cell type | 517, 8254/3 Adenocarcinoma of lung, mixed mucinous and non-mucinous | 518, 8254/3 Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous | 519, 8254/3 Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type | 520, 8254/3 Bronchiolo-alveolar carcinoma, indeterminate type | 521, 8254/3 Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type | 522, 8255/3 Adenocarcinoma with mixed subtypes | 523, 8255/3 Adenocarcinoma combined with other types of carcinoma | 524, 8256/3 Minimally invasive adenocarcinoma, non-mucinous | 525, 8257/3 Minimally invasive adenocarcinoma, mucinous | 526, 8260/0 Papillary adenoma, NOS | 527, 8260/0 Glandular papilloma | 528, 8260/1 Aggressive papillary tumor | 529, 8260/3 Papillary adenocarcinoma, NOS | 530, 8260/3 Papillary carcinoma of thyroid | 531, 8260/3 Papillary renal cell carcinoma | 532, 8261/0 Villous adenoma, NOS | 533, 8261/0 Villous papilloma | 534, 8261/2 Adenocarcinoma in situ in villous adenoma | 535, 8261/3 Adenocarcinoma in villous adenoma | 536, 8262/3 Villous adenocarcinoma | 537, 8263/0 Tubulovillous adenoma, NOS | 538, 8263/0 Villoglandular adenoma | 539, 8263/0 Papillotubular adenoma | 540, 8263/0 Tubulo-papillary adenoma | 541, 8263/2 Adenocarcinoma in situ in tubulovillous adenoma | 542, 8263/3 Adenocarcinoma in tubulovillous adenoma | 543, 8263/3 Villoglandular carcinoma | 544, 8263/3 Villoglandular variant of endometrioid adenocarcinoma | 545, 8263/3 Papillotubular adenocarcinoma | 546, 8263/3 Tubulopapillary adenocarcinoma | 547, 8264/0 Papillomatosis, glandular | 548, 8264/0 Biliary papillomatosis | 549, 8265/3 Micropapillary carcinoma, NOS | 550, 8265/3 Micropapillary adenocarcinoma | 551, 8270/0 Chromophobe adenoma | 552, 8270/3 Chromophobe carcinoma | 553, 8270/3 Chromophobe adenocarcinoma | 554, 8271/0 Lactotroph adenoma | 555, 8271/0 Prolactinoma | 556, 8272/0 Pituitary adenoma, NOS | 557, 8272/0 Corticotroph adenoma | 558, 8272/0 Null cell adenoma | 559, 8272/0 Plurihormonal adenoma | 560, 8272/0 Gonodotroph adenoma | 561, 8272/0 Somatotroph adenoma | 562, 8272/0 Thyrotroph adenoma | 563, 8272/0 Pituitary adenoma, ectopic | 564, 8272/3 Pituitary carcinoma, NOS | 565, 8273/3 Pituitary blastoma | 566, 8280/0 Acidophil adenoma | 567, 8280/0 Eosinophil adenoma | 568, 8280/3 Acidophil carcinoma | 569, 8280/3 Acidophil adenocarcinoma | 570, 8280/3 Eosinophil adenocarcinoma | 571, 8280/3 Eosinophil carcinoma | 572, 8281/0 Mixed acidophil-basophil adenoma | 573, 8281/3 Mixed acidophil-basophil carcinoma | 574, 8290/0 Oxyphilic adenoma | 575, 8290/0 Oncocytic adenoma | 576, 8290/0 Oncocytoma | 577, 8290/0 Follicular adenoma, oxyphilic cell | 578, 8290/0 Hurthle cell adenoma | 579, 8290/0 Hurthle cell tumor | 580, 8290/0 Spindle cell oncocytoma | 581, 8290/0 Oncocytic papillary cystadenoma | 582, 8290/3 Oxyphilic adenocarcinoma | 583, 8290/3 Oncocytic adenocarcinoma | 584, 8290/3 Oncocytic carcinoma | 585, 8290/3 Hurthle cell carcinoma | 586, 8290/3 Hurthle cell adenocarcinoma | 587, 8290/3 Follicular carcinoma, oxyphilic cell | 588, 8300/0 Basophil adenoma | 589, 8300/0 Mucoid cell adenoma | 590, 8300/3 Basophil carcinoma | 591, 8300/3 Basophil adenocarcinoma | 592, 8300/3 Mucoid cell adenocarcinoma | 593, 8310/0 Clear cell adenoma | 594, 8310/3 Clear cell adenocarcinoma, NOS | 595, 8310/3 Clear cell carcinoma, NOS | 596, 8310/3 Clear cell adenocarcinoma, mesonephroid | 597, 8310/3 Clear cell renal cell carcinoma, NOS | 598, 8311/1 Hypernephroid tumor | 599, 8311/3 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma | 600, 8311/3 MiT family translocation carcinoma | 601, 8311/3 Succinate dehydrogenase deficient renal cell carcinoma | 602, 8312/3 Renal cell carcinoma, NOS | 603, 8312/3 Renal cell adenocarcinoma | 604, 8312/3 Renal cell carcinoma, unclassified | 605, 8312/3 Grawitz tumor | 606, 8312/3 Hypernephroma | 607, 8313/0 Clear cell adenofibroma | 608, 8313/0 Clear cell cystadenofibroma | 609, 8313/1 Clear cell borderline tumor | 610, 8313/1 Clear cell tumor, atypical proliferative | 611, 8313/1 Clear cell cystic tumor of borderline malignancy | 612, 8313/1 Clear cell adenofibroma of borderline malignancy | 613, 8313/1 Clear cell cystadenofibroma of borderline malignancy | 614, 8313/3 Clear cell adenocarcinofibroma | 615, 8313/3 Clear cell cystadenocarcinofibroma | 616, 8314/3 Lipid-rich carcinoma | 617, 8315/3 Glycogen-rich carcinoma | 618, 8315/3 Glycogen-rich clear cell carcinoma | 619, 8316/1 Multilocular cystic renal neoplasm of low malignant potential | 620, 8316/3 Cyst-associated renal cell carcinoma | 621, 8316/3 Acquired cystic disease-associated renal cell carcinoma | 622, 8316/3 Tubulocystic renal cell carcinoma | 623, 8317/3 Renal cell carcinoma, chromophobe type | 624, 8317/3 Chromophobe cell renal carcinoma | 625, 8317/3 Hybrid oncocytic chromophobe tumor | 626, 8318/3 Renal cell carcinoma, sarcomatoid | 627, 8318/3 Renal cell carcinoma, spindle cell | 628, 8319/3 Collecting duct carcinoma | 629, 8319/3 Bellini duct carcinoma | 630, 8319/3 Renal carcinoma, collecting duct type | 631, 8320/3 Granular cell carcinoma | 632, 8320/3 Granular cell adenocarcinoma | 633, 8321/0 Chief cell adenoma | 634, 8322/0 Water-clear cell adenoma | 635, 8322/3 Water-clear cell adenocarcinoma | 636, 8322/3 Water-clear cell carcinoma | 637, 8323/0 Mixed cell adenoma | 638, 8323/1 Clear cell papillary renal cell carcinoma | 639, 8323/3 Mixed cell adenocarcinoma | 640, 8324/0 Lipoadenoma | 641, 8324/0 Adenolipoma | 642, 8325/0 Metanephric adenoma | 643, 8330/0 Follicular adenoma, NOS | 644, 8330/1 Atypical follicular adenoma | 645, 8330/3 Follicular carcinoma, NOS | 646, 8330/3 Follicular adenocarcinoma, NOS | 647, 8331/3 Follicular adenocarcinoma, well differentiated | 648, 8331/3 Follicular carcinoma, well differentiated | 649, 8332/3 Follicular adenocarcinoma, trabecular | 650, 8332/3 Follicular carcinoma, trabecular | 651, 8332/3 Follicular adenocarcinoma, moderately differentiated | 652, 8332/3 Follicular carcinoma, moderately differentiated | 653, 8333/0 Microfollicular adenoma, NOS | 654, 8333/0 Fetal adenoma | 655, 8333/3 Fetal adenocarcinoma | 656, 8334/0 Macrofollicular adenoma | 657, 8334/0 Colloid adenoma | 658, 8335/1 Follicular tumor of uncertain malignant potential | 659, 8335/1 Follicular carcinoma, encapsulated, NOS | 660, 8335/3 Follicular carcinoma, minimally invasive | 661, 8336/1 Hyalinizing trabecular tumor | 662, 8336/1 Hyalinizing trabecular adenoma | 663, 8337/3 Poorly differentiated thyroid carcinoma | 664, 8337/3 Insular carcinoma | 665, 8339/3 Follicular carcinoma, encapsulated, angioinvasive | 666, 8340/3 Papillary carcinoma, follicular variant | 667, 8340/3 Papillary adenocarcinoma, follicular variant | 668, 8340/3 Papillary and follicular adenocarcinoma | 669, 8340/3 Papillary and follicular carcinoma | 670, 8341/3 Papillary microcarcinoma | 671, 8342/3 Papillary carcinoma, oncocytic variant | 672, 8342/3 Papillary carcinoma, oxyphilic cell | 673, 8343/3 Papillary carcinoma, encapsulated, of thyroid | 674, 8344/3 Papillary carcinoma, columnar cell | 675, 8344/3 Papillary carcinoma, tall cell | 676, 8345/3 Medullary thyroid carcinoma | 677, 8345/3 C cell carcinoma | 678, 8345/3 Parafollicular cell carcinoma | 679, 8345/3 Medullary carcinoma with amyloid stroma | 680, 8346/3 Mixed medullary-follicular carcinoma | 681, 8347/3 Mixed medullary-papillary carcinoma | 682, 8348/1 Well differentiated tumor of uncertain malignant potential | 683, 8349/1 Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) | 684, 8350/3 Nonencapsulated sclerosing carcinoma | 685, 8350/3 Nonencapsulated sclerosing adenocarcinoma | 686, 8350/3 Nonencapsulated sclerosing tumor | 687, 8350/3 Papillary carcinoma, diffuse sclerosing | 688, 8360/1 Multiple endocrine adenomas | 689, 8360/1 Endocrine adenomatosis | 690, 8361/0 Juxtaglomerular tumor | 691, 8361/0 Juxtaglomerular cell tumor | 692, 8361/0 Reninoma | 693, 8370/0 Adrenal cortical adenoma, NOS | 694, 8370/0 Adrenal cortical tumor, NOS | 695, 8370/0 Adrenal cortical tumor, benign | 696, 8370/3 Adrenal cortical carcinoma | 697, 8370/3 Adrenal cortical adenocarcinoma | 698, 8370/3 Adrenal cortical tumor, malignant | 699, 8371/0 Adrenal cortical adenoma, compact cell | 700, 8372/0 Adrenal cortical adenoma, pigmented | 701, 8372/0 Black adenoma | 702, 8372/0 Pigmented adenoma | 703, 8373/0 Adrenal cortical adenoma, clear cell | 704, 8374/0 Adrenal cortical adenoma, glomerulosa cell | 705, 8375/0 Adrenal cortical adenoma, mixed cell | 706, 8380/0 Endometrioid adenoma, NOS | 707, 8380/0 Endometrioid cystadenoma, NOS | 708, 8380/1 Endometrioid adenoma, borderline malignancy | 709, 8380/1 Endometrioid tumor, borderline | 710, 8380/1 Atypical proliferative endometrioid tumor | 711, 8380/1 Endometrioid cystadenoma, borderline malignancy | 712, 8380/1 Endometrioid tumor of low malignant potential | 713, 8380/2 Endometrioid intraepithelial neoplasia | 714, 8380/2 Atypical hyperplasia of endometrium | 715, 8380/3 Endometrioid adenocarcinoma, NOS | 716, 8380/3 Endometrioid carcinoma, NOS | 717, 8380/3 Endometrioid cystadenocarcinoma | 718, 8381/0 Endometrioid adenofibroma, NOS | 719, 8381/0 Endometrioid cystadenofibroma, NOS | 720, 8381/1 Endometrioid adenofibroma, borderline malignancy | 721, 8381/1 Endometrioid cystadenofibroma, borderline malignancy | 722, 8381/3 Endometrioid adenofibroma, malignant | 723, 8381/3 Endometrioid cystadenofibroma, malignant | 724, 8382/3 Endometrioid adenocarcinoma, secretory variant | 725, 8383/3 Endometrioid adenocarcinoma, ciliated cell variant | 726, 8384/3 Adenocarcinoma, endocervical type, NOS | 728, 8390/0 Skin appendage adenoma | 729, 8390/0 Adnexal tumor, benign | 730, 8390/0 Skin appendage tumor, benign | 731, 8390/3 Adnexal ",,,,,,,,,,,,
tumor_diag_topography,cancer_history_details,,dropdown,Tumor diagnosis topography ,"1, C00.0 External lip upper | 2, C00.1 External lip lower | 3, C00.2 External lip NOS | 4, C00.3 Upper lip, mucosa | 5, C00.4 Lower lip, mucosa | 6, C00.5 Mucosa lip, NOS | 7, C00.6 Commissure lip | 8, C00.8 Overlapping lesion of lip | 9, C01.9 Base of tongue, NOS | 10, C02.0 Dorsal surface tongue, NOS | 11, C02.1 Border of tongue | 12, C02.2 Ventral surface of tongue NOS | 13, C02.3 Anterior 2/3 of tongue NOS | 14, C02.4 Lingual tonsil | 15, C02.8 Overlapping lesion of tongue | 16, C02.9 Tongue NOS | 17, C03.0 Upper gum | 18, C03.1 Lower gum | 19, C03.9 Gum NOS | 20, C04.0 Anterior floor of mouth | 21, C04.1 Lateral floor of mouth | 22, C04.8 Overlapping lesion of floor of mouth | 23, C04.9 Floor of mouth NOS | 24, C05.0 Hard palate | 25, C05.1 Soft palate NOS (excludes Nasopharyngcal surface C11.3) | 26, C05.2 Uvula | 27, C05.8 Overlapping lesion of palate | 28, C05.9 Palate NOS | 29, C06.0 Cheek mucosa | 30, C06.1 Vestibule of mouth | 31, C06.2 Retromolar area | 32, C06.8 Overlapping lesion of other and unspecified parts of mouth | 33, C06.9 Mouth NOS | 34, C07.9 Parotid gland | 35, C08.0 Submaxillary gland | 36, C08.1 Sublingual gland | 37, C08.8 Overlapping lesion of major salivary glands | 38, C08.9 Major salivary gland, NOS | 39, C09.0 Tonsillar fossa | 40, C09.1 Tonsillar pillar | 41, C09.8 Overlapping lesion of tonsil | 42, C09.9 Tonsil NOS (excludes Lingual tonsil C02.4 and Pharyngeal tonsil C11.1) | 43, C10.0 Vallecula | 44, C10.1 Anterior surface of epiglottis | 45, C10.2 Lateral wall oropharynx | 46, C10.3 Posterior wall oropharynx | 47, C10.4 Branchial cleft (site of neoplosm) | 48, C10.8 Overlapping lesion of oropharynx | 49, C10.9 Oropharynx NOS | 50, C11.0 Superior wall of nasopharynx | 51, C11.1 Posterior wall nasopharynx | 52, C11.2 Lateral wall nasopharynx | 53, C11.3 Anterior wall nasopharynx | 54, C11.8 Overlapping lesion of nasopharynx | 55, C11.9 Nasopharynx NOS | 56, C12.9 Pyriform sinus | 57, C13.0 Postcricoid region | 58, C13.1 Hypopharyngeal aspect of aryepiglottic fold | 59, C13.2 Posterior wall hypopharynx | 60, C13.8 Overlapping lesion of hypopharynx | 61, C13.9 Hypopharynx, NOS | 62, C14.0 Pharynx NOS | 63, C14.2 Waldeyer's ring | 64, C14.8 Overlapping lesion of lip, oral cavity and pharynx | 65, C15.0 Cervical esophagus | 66, C15.1 Thoracic esophagus | 67, C15.2 Abdominal esophagus | 68, C15.3 Upper third of esophagus | 69, C15.4 Middle third of esophagus | 70, C15.5 Esophagus lower third | 71, C15.8 Overlapping lesion of esophagus | 72, C15.9 Esophagus NOS | 73, C16.0 Cardia, NOS | 74, C16.1 Fundus stomach | 75, C16.2 Body stomach | 76, C16.3 Gastric antrum | 77, C16.4 Pylorus | 78, C16.5 Lesser curvature of stomach, NOS (not classifiable to C16.1 to C16.4) | 79, C16.6 Greater curvature of stomach, NOS (not classifiable to C16.0 to C16.4) | 80, C16.8 Overlapping lesion of stomach | 81, C16.9 Stomach NOS | 82, C17.0 Duodenum | 83, C17.1 Jejunum | 84, C17.2 Ileum (excludes ileocecal valve C18.0) | 85, C17.3 Meckel's diverticulum (site of neoplasm) | 86, C17.8 Overlapping lesion of small intestine | 87, C17.9 Small intestine NOS | 88, C18.0 Cecum | 89, C18.1 Appendix | 90, C18.2 Ascending colon | 91, C18.3 Hepatic flexure of colon | 92, C18.4 Transverse colon | 93, C18.5 Splenic flexure of colon | 94, C18.6 Descending colon | 95, C18.7 Sigmoid colon | 96, C18.8 Overlapping lesion of colon | 97, C18.9 Colon NOS | 98, C19.9 Rectosigmoid junction | 99, C20.9 Rectum, NOS | 100, C21.0 Anus, NOS (excludes Skin of anus and Perianal skin (C44.5) | 101, C21.1 Anal canal | 102, C21.2 Cloacogenic zone | 103, C21.8 Overlapping lesion of rectum, anus and anal canal | 104, C22.0 Liver | 105, C22.1 Intrahepatic bile duct | 106, C23.9 Gallbladder | 107, C24.0 Extrahepatic bile duct | 108, C24.1 Ampulla of Vater | 109, C24.8 Overlapping lesion of biliary tract | 110, C24.9 Biliary tract, NOS | 111, C25.0 Head of pancreas | 112, C25.1 Body pancreas | 113, C25.2 Tail pancreas | 114, C25.3 Pancreatic duct | 115, C25.4 Islets of Langerhans | 116, C25.7 Neck of pancreas | 117, C25.8 Overlapping lesion of pancreas | 118, C25.9 Pancreas NOS | 119, C26.0 Intestinal tract, NOS | 120, C26.8 Overlapping lesion of digestive system | 121, C26.9 Gastrointestinal tract, NOS | 122, C30.0 Nasal cavity (excludes Nose, NOS C76.0) | 123, C30.1 Middle ear | 124, C31.0 Maxillary sinus | 125, C31.1 Ethmoid sinus | 126, C31.2 Frontal sinus | 127, C31.3 Sphenoid sinus | 128, C31.8 Overlapping lesion of accessory sinuses | 129, C31.9 Accessory sinus, NOS | 130, C32.0 Glottis | 131, C32.1 Supraglottis | 132, C32.2 Subglottis | 133, C32.3 Laryngeal cartilage | 134, C32.8 Overlapping lesion of larynx | 135, C32.9 Larynx NOS | 136, C33.9 Trachea | 137, C34.0 Main bronchus | 138, C34.1 Upper lobe, lung | 139, C34.2 Middle lobe, lung | 140, C34.3 Lower lobe, lung | 141, C34.8 Overlapping lesion of lung | 142, C34.9 Lung NOS | 143, C37.9 Thymus | 144, C38.0 Heart | 145, C38.1 Anterior mediastinum | 146, C38.2 Posterior mediastinum | 147, C38.3 Mediastinum NOS | 148, C38.4 Pleura NOS | 149, C38.8 Overlapping lesion of heart, mediastinum and pleura | 150, C39.0 Upper respiratory tract, NOS | 151, C39.8 Overlapping lesion of respiratory system and intrathoracic organs | 152, C39.9 Respiratory tract, NOS | 153, C40.0 Upper limb long bones, joints | 154, C40.1 Upper limb short bones, joints | 155, C40.3 Lower limb short bones, joints | 156, C40.8 Overlapping lesion of bones, joints and articular cartilage of limbs | 157, C40.9 Bone limb, NOS | 158, C41.0 Skull and facial bone | 159, C41.1 Mandible | 160, C41.2 Vertebral column (excludes Sacrum and Coccyx C41.4) | 161, C41.3 Rib, sternum, clavicle | 162, C41.4 Pelvic bone | 163, C41.8 Overlapping lesion of bones, joints and articular cartilage | 164, C41.9 Bone NOS | 165, C42.0 Blood | 166, C42.1 Bone marrow | 167, C42.2 Spleen | 168, C42.3 Reticuloendothelial system, NOS | 169, C42.4 Hematopoietic system, NOS | 170, C44.0 Skin lip, NOS | 171, C44.1 Eyelid NOS | 172, C44.2 External ear | 173, C44.3 Skin face | 174, C44.4 Skin scalp, neck | 175, C44.5 Skin trunk | 176, C44.6 Skin limb, upper | 177, C44.7 Skin limb, lower | 178, C47.0 Peripheral nerve head, neck | 179, C47.1 Peripheral nerve shoulder, arm | 180, C47.2 Peripheral nerve leg | 181, C47.3 Peripheral nerve thorax (excludes Thymus, Heart and Mediastinum C37. , C38. ) | 182, C47.4 Peripheral nerve abdomen | 183, C47.5 Peripheral nerve pelvis | 184, C47.6 Peripheral nerve trunk | 185, C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system | 186, C47.9 Autonomic nervous system NOS | 187, C48.0 Retroperitoneum | 188, C48.1 Peritoneum | 189, C48.2 Peritoneum NOS | 190, C48.8 Overlapping lesion of retroperitoneum and peritoneum | 191, C49.0 Connective tissue head | 192, C49.1 Connective tissue arm | 193, C49.2 Connective tissue leg | 194, C49.3 Connective tissue thorax (excludes Thymus, Heart and Mediastinum C37. , C38. ) | 195, C49.4 Connective tissue abdomen | 196, C49.5 Connective tissue pelvis | 197, C49.6 Connective tissue trunk, NOS | 198, C49.8 Overlapping lesion of connective, subcutaneous and other soft tissues | 199, C49.9 Connective tissue NOS | 200, C50.0 Nipple | 201, C50.1 Central portion of breast | 202, C50.2 Upper inner quadrant of breast | 203, C50.3 Lower inner quadrant of breast | 204, C50.4 Upper outer quadrant of breast | 205, C50.5 Lower outer quadrant of breast | 206, C50.6 Axillary tail of breast | 207, C50.8 Overlapping lesion of breast | 208, C50.9 Breast NOS (excludes Skin of breast C44.5) | 209, C51.0 Labium majus | 210, C51.1 Labium minus | 211, C51.2 Clitoris | 212, C51.8 Overlapping lesion of vulva | 213, C51.9 Vulva, NOS | 214, C52.9 Vagina, NOS | 215, C53.0 Endocervix | 216, C53.1 Exocervix | 217, C53.8 Overlapping lesion of cervix uteri | 218, C53.9 Cervix uteri | 219, C54.0 Isthmus uteri | 220, C54.1 Endometrium | 221, C54.2 Myometrium | 222, C54.3 Fundus uteri | 223, C54.8 Overlapping lesion of corpus uteri | 224, C54.9 Corpus uteri | 225, C55.9 Uterus NOS | 226, C56.9 Ovary | 227, C57.0 Fallopian tube | 228, C57.1 Broad ligament | 229, C57.2 Round ligament | 230, C57.3 Parametrium | 231, C57.4 Uterine adnexa | 232, C57.7 Wolffian body | 233, C57.8 Overlapping lesion of female genital organs | 234, C57.9 Female genital tract, NOS | 235, C60.0 Prepuce | 236, C60.1 Glans penis | 237, C60.2 Body penis | 238, C60.8 Overlapping lesion of penis | 239, C60.9 Penis NOS | 240, C61.9 Prostate gland | 241, C62.0 Undescended testis (site of neoplasm) | 242, C62.1 Descended testis | 243, C62.9 Testis NOS | 244, C63.0 Epididymis | 245, C63.1 Spermatic cord | 246, C63.2 Scrotum, NOS | 247, C63.7 Tunica vaginalis | 248, C63.8 Overlapping lesion of male genital organs | 249, C63.9 Male genital organs, NOS | 250, C64.9 Kidney NOS | 251, C65.9 Renal pelvis | 252, C66.9 Ureter | 253, C67.0 Trigone, bladder | 254, C67.1 Dome, bladder | 255, C67.2 Lateral wall bladder | 256, C67.4 Posterior wall bladder | 257, C67.6 Ureteric orifice | 258, C67.7 Urachus | 259, C67.8 Overlapping lesion of bladder | 260, C67.9 Bladder NOS | 261, C68.0 Urethra | 262, C68.1 Paraurethral gland | 263, C68.8 Overlapping lesion of urinary organs | 264, C68.9 Urinary system, NOS | 265, C69.0 Conjunctiva | 266, C69.1 Cornea, NOS | 267, C69.2 Retina | 268, C69.3 Choroid | 269, C69.4 Ciliary body | 270, C69.5 Lacrimal gland | 271, C69.6 Orbit NOS | 272, C69.8 Overlapping lesion of eye and adnexa | 273, C69.9 Eye NOS | 274, C70.0 Cerebral meninges | 275, C70.1 Spinal meninges | 276, C70.9 Meninges NOS | 277, C71.0 Cerebrum | 278, C71.1 Frontal lobe | 279, C71.2 Temporal lobe | 280, C71.3 Parietal lobe | 281, C71.4 Occipital lobe | 282, C71.5 Ventricle NOS | 283, C71.6 Cerebellum, NOS | 284, C71.7 Brain stem | 285, C71.8 Overlapping lesion of brain | 286, C71.9 Brain NOS | 287, C72.0 Spinal cord | 288, C72.1 Cauda equina | 289, C72.2 Olfactory nerve | 290, C72.3 Optic nerve | 291, C72.4 Acoustic nerve | 292, C72.5 Cranial nerve, NOS | 293, C72.8 Overlapping lesion of brain and central nervous system | 294, C72.9 Nervous system NOS | 295, C73.9 Thyroid gland | 296, C74.0 Adrenal gland cortex | 297, C74.1 Adrenal gland medulla | 298, C74.9 Adrenal gland NOS | 299, C75.0 Parathyroid gland | 300, C75.1 Pituitary gland | 301, C75.2 Craniopharyngeal duct | 302, C75.3 Pineal gland | 303, C75.4 Carotid body | 304, C75.5 Aortic body | 305, C75.8 Overlapping lesion of endocrine glands and related structures | 306, C75.9 Endocrine gland, NOS | 307, C76.0 Head, face or neck NOS | 308, C76.1 Thorax NOS | 309, C76.2 Abdomen NOS | 310, C76.3 Pelvis NOS | 311, C76.4 Upper limb NOS | 312, C76.5 Lower limb NOS | 313, C76.7 Other illdefined sites | 314, C76.8 Overlapping lesion of ill-defined sites | 315, C77.0 Lymph node face, head ,neck | 316, C77.1 Intrathoracic lymph node | 317, C77.2 Intra-abdominal lymph nodes | 318, C77.3 Lymph node axilla, arm | 319, C77.4 Lymph node inguinal region, leg | 320, C77.5 Lymph node pelvic | 321, C77.8 Lymph nodes of multiple regions | 322, C77.9 Lymph node NOS | 9999, C80.9 Unknown primary site",ICD-O topography code of the neoplasm (primary tumor site),autocomplete,,,,,,,,,,
tumor_diagnosis_age,cancer_history_details,,text,Age at tumor diagnosis (in months),,,,,,,,,,,,, @READONLY
diagnosis_confirmation,cancer_history_details,,dropdown,Confirmation of diagnosis,"1, Pathology/lab report | 2, Medical record note | 3, Death certificate | 4, Self-report",Source document used to confirm diagnosis,autocomplete,,,,,,,,,,
tumor_stage,cancer_history_details,,dropdown,Tumor stage,"1, Localized | 2, Regionally advanced | 3, Metastatic | 4, Stage I | 5, Stage II | 6, Stage III | 7, Stage IV | 8, L1 | 9, L2 | 10, M | 11, MS | 9999, Unknown | 9997, Not reported | 9996, Not applicable",The stage of the tumor at diagnosis ,autocomplete,,,,,,,,,,
specific_stage,cancer_history_details,,text,Specific stage,,,,,,,[tumor_stage] = '1' or [tumor_stage] = '2' or [tumor_stage] = '3' or [tumor_stage] = '4' or [tumor_stage] = '5' or [tumor_stage] = '6' or [tumor_stage] = '7' or [tumor_stage] = '8' or [tumor_stage] = '9' or [tumor_stage] = '10' or [tumor_stage] = '11',,,,,,
staging_system,cancer_history_details,,dropdown,Staging system,"1, AIDS-Related Kaposi Sarcoma Stage | 2, AJCC v6 Stage | 3, AJCC v7 Stage | 4, AJCC v8 Stage | 5, Ann Arbor Lymphoma Staging System | 6, Childrens Oncology Group Liver Tumor Staging System | 7, Childrens Oncology Group Neuroblastoma Risk Group Staging System | 8, Childrens Oncology Group Renal Cancer Staging System | 9, Childrens Oncology Group Retinoblastoma Risk Group Staging System | 10, Childrens Oncology Group Staging System | 11, Childrens Oncology Group/National Wilms Tumor Study Group Staging System | 12, Enneking Staging System | 13, Evans Staging System | 14, FIGO Stage | 15, Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System | 16, International Neuroblastoma Risk Group Staging System | 17, International Neuroblastoma Staging System | 18, International Society of Pediatric Oncology Staging System | 19, Lugano Stage | 20, Pediatric Oncology Group Neuroblastoma Staging System | 21, PRETEXT Staging System | 22, Reese-Ellsworth Staging System | 23, St. Jude Stage | 24, TNM Staging System | 9997, Not reported | 9999, Unknown",,autocomplete,,,,[tumor_stage] = '1' or [tumor_stage] = '2' or [tumor_stage] = '3' or [tumor_stage] = '4' or [tumor_stage] = '5' or [tumor_stage] = '6' or [tumor_stage] = '7' or [tumor_stage] = '8' or [tumor_stage] = '9' or [tumor_stage] = '10' or [tumor_stage] = '11',,,,,,
tumor_size,cancer_history_details,,text,Tumor size,,"If this is a solid tumor, the dimensions of the primary tumor in cm (all dimensions provided).  If not a solid tumor, type ""not applicable"".",,,,,,,,,,,
surgical_resection,cancer_history_details,,dropdown,Extent of surgical resection,"1, R0 - Complete Resection, Negative Margins | 2, R1 - Complete Resection, Positive Margins | 3, R2 - Gross Residual Disease | 4, No surgical resection | 9999, Unknown | 9997, Not Reported","If this is a solid tumor, was this a primary complete resection?",autocomplete,,,,,,,,,,
tumor_rupture,cancer_history_details,,yesno,Tumor rupture ,,"If this is a solid tumor, was there pre-surgical tumor rupture?",,,,,,,,,,,
surg_complications,cancer_history_details,,dropdown,Surgical complications ,"1, Bleed | 2, Intra-operative tumor rupture | 3, For CNS tumors:  urgent surgery for ICP | 9998, Other | 9999, Unknown | 9997, Not reported | 9996, Not applicable",,autocomplete,,,,,,,,,,
other_surg_complications,cancer_history_details,,text,Other surgical complications ,,,,,,,[surg_complications] = '9998',,,,,,
renal_tumor_surg,cancer_history_details,,yesno,Renal tumor surgery,,"If this is a renal tumor, was nephron-sparing surgery/partial nephrectomy performed?",,,,,,,,,,,
limb_surgery,cancer_history_details,,dropdown,Limb surgery,"1, Amputation | 2, Limb salvage procedure | 9998, Other | 9999, Unknown | 9997, Not reported | 9996, Not applicable",,autocomplete,,,,,,,,,,
other_limb_surgery,cancer_history_details,,text,Other Limb surgery,,,,,,,[limb_surgery]='9998',,,,,,
detection_type,cancer_history_details,,radio,Type of detection,"1, Surveillance | 2, Symptomatic",The way the tumor was first brought to attention,,,,,,,,,,,
surveillance_method,cancer_history_details,,checkbox,Method of detection surveillance,"1, Ultrasound | 2, CT scan | 3, Brain MRI | 4, WBMRI | 5, Colonoscopy/flexible sigmoidoscopy | 6, Blood or urine test | 7, Physical exam | 9996, Not applicable | 9999, Unknown",The way the tumor was first brought to attention,,,,,[detection_type] = '1',,,,,,
clinical_trial_initial,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #1e33ea;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at initial diagnosis,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,,,,,,,
tox_delay_initial,cancer_history_details,,yesno,Treatment toxicity delay at initial diagnosis,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_initial]='1',,,,,,
tox_grade_events_initial,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events at initial diagnosis,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_initial]='1',,,,,,
tox_dose_reductions_initial,cancer_history_details,,dropdown,Treatment toxicity dose reductions at initial diagnosis,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_initial]='1',,,,,,
radiation_therapy_inital,cancer_history_details,,dropdown,Radiation therapy at initial diagnosis,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,,,,,,,
tumor_seq_data_initial,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #1e33ea;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at initial diagnosis,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,,,,,,,
other_tumor_seq_data_initial,cancer_history_details,,text,Other tumor sequencing data at initial diagnosis,,Specify the type of sequencing data,,,,,[tumor_seq_data_initial(9998)] = '1',,,,,,
tumor_status,cancer_history_details,,yesno,Has the patient had a relapse or progression for this tumor?,,,,,,,,,,,,,
relap_prog,cancer_history_details,,checkbox,Relapse or progression?,"1, Relapse | 2, Progression",Note: relapses and progressions must be added in ascending order,,,,,[tumor_status] = '1',,,,,,
start_relap1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #1e33ea;"">Tumor Relapses</span></p></div>",dropdown,Relapse number,"1, Relapse 1 | 2, Relapse 2 | 3, Relapse 3 | 4, Relapse 4 | 5, Relapse 5 | 6, Relapse 6 | 7, Relapse 7 | 8, Relapse 8 | 9, Relapse 9 | 10, Relapse 10",,autocomplete,,,,[relap_prog(1)] = '1',,,,,,
relap1_age,cancer_history_details,,text,Age at relapse 1 (in months),,,,,,,[start_relap1]='1',,,,,, @READONLY
relap1_site,cancer_history_details,,dropdown,Site of relapse 1,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of relapsed disease,autocomplete,,,,[start_relap1]='1',,,,,,
clinical_trial_relap1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at relapse 1,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[start_relap1]='1',,,,,,
tox_delay_relap1,cancer_history_details,,yesno,Treatment toxicity delay at relapse 1,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_relap1] = '1',,,,,,
tox_grade_events_relap1,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events at relapse 1,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_relap1] = '1',,,,,,
tox_dose_reductions_relap1,cancer_history_details,,dropdown,Treatment toxicity dose reductions at relapse 1,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_relap1] = '1',,,,,,
radiation_therapy_relap1,cancer_history_details,,dropdown,Radiation therapy at relapse 1,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[start_relap1]='1',,,,,,
tumor_seq_data_relap1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at relapse 1,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[start_relap1]='1',,,,,,
other_tumor_seq_data_relap1,cancer_history_details,,text,Other tumor sequencing data at relapse 1,,Specify the type of sequencing data,,,,,[tumor_seq_data_relap1(9998)] = '1',,,,,,
add_relap2,cancer_history_details,,yesno,Has the patient had any additional relapses for this tumor?,,,,,,,[start_relap1]=1,,,,,,
add_relap_num2,cancer_history_details,,dropdown,Additional relapse number,"1, Relapse 1 | 2, Relapse 2 | 3, Relapse 3 | 4, Relapse 4 | 5, Relapse 5 | 6, Relapse 6 | 7, Relapse 7 | 8, Relapse 8 | 9, Relapse 9 | 10, Relapse 10",,autocomplete,,,,[add_relap2]='1',,,,,,
relap2_age,cancer_history_details,,text,Age at relapse 2 (in months),,,,,,,[add_relap_num2]='2',,,,,, @READONLY
clinical_trial_relap2,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at relapse 2,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_relap_num2]='2',,,,,,
tox_delay_relap2,cancer_history_details,,yesno,Treatment toxicity delay at relapse 2,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_relap2] = '1',,,,,,
tox_grade_events_relap2,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events at relapse 2,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_relap2] = '1',,,,,,
tox_dose_reductions_relap2,cancer_history_details,,dropdown,Treatment toxicity dose reductions at relapse 2,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_relap2] = '1',,,,,,
radiation_therapy_relap2,cancer_history_details,,dropdown,Radiation therapy at relapse 2,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_relap_num2]='2',,,,,,
tumor_seq_data_relap2,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at relapse 2,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_relap_num2]='2',,,,,,
other_tumor_seq_data_relap2,cancer_history_details,,text,Other tumor Sequencing data at relapse 2,,,,,,,[tumor_seq_data_relap2(9998)] = '1',,,,,,
add_relap3,cancer_history_details,,yesno,Has the patient had any additional relapses for this tumor?,,,,,,,[add_relap_num2]='2',,,,,,
add_relap_num3,cancer_history_details,,dropdown,Additional relapse number,"1, Relapse 1 | 2, Relapse 2 | 3, Relapse 3 | 4, Relapse 4 | 5, Relapse 5 | 6, Relapse 6 | 7, Relapse 7 | 8, Relapse 8 | 9, Relapse 9 | 10, Relapse 10",,autocomplete,,,,[add_relap3]='1',,,,,,
relap3_age,cancer_history_details,,text,Age at relapse 3 (in months),,,,,,,[add_relap_num3]='3',,,,,, @READONLY
relap3_site,cancer_history_details,,dropdown,Site of relapse 3,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of relapsed disease,autocomplete,,,,[add_relap_num3]='3',,,,,,
clinical_trial_relap3,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at relapse 3,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_relap_num3]='3',,,,,,
tox_delay_relap3,cancer_history_details,,yesno,Treatment toxicity delay at relapse 3,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_relap3] = '1',,,,,,
tox_grade_events_relap3,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events at relapse 3,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_relap3] = '1',,,,,,
tox_dose_reductions_relap3,cancer_history_details,,dropdown,Treatment toxicity dose reductions at relapse 3,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_relap3] = '1',,,,,,
radiation_therapy_relap3,cancer_history_details,,dropdown,Radiation therapy at relapse 3,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_relap_num3]='3',,,,,,
tumor_seq_data_relap3,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at relapse 3,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_relap_num3]='3',,,,,,
other_tumor_seq_data_relap3,cancer_history_details,,text,Other tumor sequencing data at relapse 3,,,,,,,[tumor_seq_data_relap3(9998)] = '1',,,,,,
add_relap4,cancer_history_details,,yesno,Has the patient had any additional relapses for this tumor?,,,,,,,[add_relap_num3]='3',,,,,,
add_relap_num4,cancer_history_details,,dropdown,Additional relapse number,"1, Relapse 1 | 2, Relapse 2 | 3, Relapse 3 | 4, Relapse 4 | 5, Relapse 5 | 6, Relapse 6 | 7, Relapse 7 | 8, Relapse 8 | 9, Relapse 9 | 10, Relapse 10",,autocomplete,,,,[add_relap4]='1',,,,,,
relap4_age,cancer_history_details,,text,Age at relapse 4 (in months),,,,,,,[add_relap_num4]=4,,,,,, @READONLY
relap4_site,cancer_history_details,,dropdown,Site of relapse 4,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of relapsed disease,autocomplete,,,,[add_relap_num4]='4',,,,,,
clinical_trial_relap4,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at relapse 4,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_relap_num4]='4',,,,,,
tox_delay_relap4,cancer_history_details,,yesno,Treatment toxicity delay at relapse 4,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_relap4] = '1',,,,,,
tox_grade_events_relap4,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events at relapse 4,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_relap4] = '1',,,,,,
tox_dose_reductions_relap4,cancer_history_details,,dropdown,Treatment toxicity dose reductions at relapse 4,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_relap4] = '1',,,,,,
radiation_therapy_relap4,cancer_history_details,,dropdown,Radiation therapy at relapse 4,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_relap_num4]='4',,,,,,
tumor_seq_data_relap4,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at relapse 4,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_relap_num4]='4',,,,,,
other_tumor_seq_data_relap4,cancer_history_details,,text,Other tumor sequencing data at relapse 4,,,,,,,[tumor_seq_data_relap4(9998)] = '1',,,,,,
add_relap5,cancer_history_details,,yesno,Has the patient had any additional relapses for this tumor?,,,,,,,[add_relap_num4]='4',,,,,,
add_relap_num5,cancer_history_details,,dropdown,Additional relapse number,"1, Relapse 1 | 2, Relapse 2 | 3, Relapse 3 | 4, Relapse 4 | 5, Relapse 5 | 6, Relapse 6 | 7, Relapse 7 | 8, Relapse 8 | 9, Relapse 9 | 10, Relapse 10",,autocomplete,,,,[add_relap5]='1',,,,,,
relap5_age,cancer_history_details,,text,Age at relapse 5 (in months),,,,,,,[add_relap_num5]=5,,,,,, @READONLY
relap5_site,cancer_history_details,,dropdown,Site of relapse 5,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of relapsed disease,autocomplete,,,,[add_relap_num5]='5',,,,,,
clinical_trial_relap5,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at relapse 5,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_relap_num5]='5',,,,,,
tox_delay_relap5,cancer_history_details,,yesno,Treatment toxicity delay at relapse 5,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_relap5] = '1',,,,,,
tox_dose_reductions_relap5,cancer_history_details,,dropdown,Treatment toxicity dose reductions at relapse 5,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_relap5] = '1',,,,,,
radiation_therapy_relap5,cancer_history_details,,dropdown,Radiation therapy at relapse 5,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_relap_num5]='5',,,,,,
tumor_seq_data_relap5,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at relapse 5,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_relap_num5]='5',,,,,,
other_tumor_seq_data_relap5,cancer_history_details,,text,Other tumor sequencing data at relapse 5,,,,,,,[tumor_seq_data_relap5(9998)] = '1',,,,,,
start_prog1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #1c00ff;"">Tumor Progressions </span></p></div>",dropdown,Progression number,"1, Progression 1 | 2, Progression 2 | 3, Progression 3 | 4, Progression 4 | 5, Progression 5 | 6, Progression 6 | 7, Progression 7 | 8, Progression 8 | 9, Progression 9 | 10, Progression 10",,autocomplete,,,,[relap_prog(2)] = '1',,,,,,
prog1_age,cancer_history_details,,text,Age at progression 1 (in months),,,,,,,[start_prog1]='1',,,,,, @READONLY
prog1_site,cancer_history_details,,dropdown,Site of progression 1,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of disease progression,autocomplete,,,,[start_prog1]='1',,,,,,
transformation_prog1,cancer_history_details,,yesno,Transformation of progression 1,,Is this a progression that is suspected to be a transformation from a low grade to a high grade tumor?,,,,,[start_prog1]='1',,,,,,
trans_confirm_prog1,cancer_history_details,,dropdown,Transformation confirmation of progression 1,"1, Confirmed based on pathology | 2, Suspected based on imaging | 9996, Not applicable",Basis of suspicion for transformation event ,autocomplete,,,,[transformation_prog1]='1',,,,,,
clinical_trial_prog1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at progression 1,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[start_prog1]='1',,,,,,
tox_delay_prog1,cancer_history_details,,yesno,Treatment toxicity delay at progression 1,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_prog1] = '1',,,,,,
tox_grade_events_prog1,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events progression 1,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_prog1] = '1',,,,,,
tox_dose_reductions_prog1,cancer_history_details,,dropdown,Treatment toxicity dose reductions at progression 1,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_prog1] = '1',,,,,,
radiation_therapy_prog1,cancer_history_details,,dropdown,Radiation therapy at progression 1,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[start_prog1]='1',,,,,,
tumor_seq_data_prog1,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at progression 1,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[start_prog1]='1',,,,,,
other_tumor_seq_data_prog1,cancer_history_details,,text,Other tumor sequencing data at progression 1,,Specify the type of sequencing data,,,,,[tumor_seq_data_prog1(9998)] = '1',,,,,,
add_prog2,cancer_history_details,,yesno,Has the patient had any additional progressions for this tumor?,,,,,,,[start_prog1]=1,,,,,,
add_prog_num2,cancer_history_details,,dropdown,Additional progression number,"1, Progression 1 | 2, Progression 2 | 3, Progression 3 | 4, Progression 4 | 5, Progression 5 | 6, Progression 6 | 7, Progression 7 | 8, Progression 8 | 9, Progression 9 | 10, Progression 10",,autocomplete,,,,[add_prog2]='1',,,,,,
prog2_age,cancer_history_details,,text,Age at progression 2 (in months),,,,,,,[add_prog_num2]='2',,,,,, @READONLY
prog2_site,cancer_history_details,,dropdown,Site of progression 2,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of disease progression,autocomplete,,,,[add_prog_num2]='2',,,,,,
transformation_prog2,cancer_history_details,,yesno,Transformation of progression 2,,Is this a progression that is suspected to be a transformation from a low grade to a high grade tumor?,,,,,[add_prog_num2]='2',,,,,,
trans_confirm_prog2,cancer_history_details,,dropdown,Transformation confirmation of progression 2,"1, Confirmed based on pathology | 2, Suspected based on imaging | 9996, Not applicable",Basis of suspicion for transformation event ,autocomplete,,,,[transformation_prog2]='1',,,,,,
clinical_trial_prog2,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at progression 2,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_prog_num2]='2',,,,,,
tox_delay_prog2,cancer_history_details,,yesno,Treatment toxicity delay at progression 2,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_prog2] = '1',,,,,,
tox_grade_events_prog2,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events progression 2,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_prog2] = '1',,,,,,
tox_dose_reductions_prog2,cancer_history_details,,dropdown,Treatment toxicity dose reductions at progression 2,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_prog2] = '1',,,,,,
radiation_therapy_prog2,cancer_history_details,,dropdown,Radiation therapy at progression 2,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_prog_num2]='2',,,,,,
tumor_seq_data_prog2,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at progression 2,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_prog_num2]='2',,,,,,
other_tumor_seq_data_prog2,cancer_history_details,,text,Other tumor sequencing data at progression 2,,Specify the type of sequencing data,,,,,[tumor_seq_data_prog2(9998)] = '1',,,,,,
add_prog3,cancer_history_details,,yesno,Has the patient had any additional progressions for this tumor?,,,,,,,[add_prog_num2]='2',,,,,,
add_prog_num3,cancer_history_details,,dropdown,Additional progression number,"1, Progression 1 | 2, Progression 2 | 3, Progression 3 | 4, Progression 4 | 5, Progression 5 | 6, Progression 6 | 7, Progression 7 | 8, Progression 8 | 9, Progression 9 | 10, Progression 10",,autocomplete,,,,[add_prog3]='1',,,,,,
prog3_age,cancer_history_details,,text,Age at progression 3 (in months),,,,,,,[add_prog_num3]='3',,,,,, @READONLY
prog3_site,cancer_history_details,,dropdown,Site of progression 3,"1, Localized | 2, Metastatic | 3, Both localized and metastatic | 9999, Unknown",The site of disease progression,autocomplete,,,,[add_prog_num3]=3,,,,,,
transformation_prog3,cancer_history_details,,yesno,Transformation of progression 3,,Is this a progression that is suspected to be a transformation from a low grade to a high grade tumor?,,,,,[add_prog_num3]='3',,,,,,
clinical_trial_prog3,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Therapy</span></p></div>",dropdown,Clinical trial treatment at progression 3,"1, Yes | 0, No | 9999, Unknown",Whether the subject was treated on a clinical trial,autocomplete,,,,[add_prog_num3]='3',,,,,,
tox_delay_prog3,cancer_history_details,,yesno,Treatment toxicity delay at progression 3,,Specify whether had treatment delays due to toxicity,,,,,[clinical_trial_prog3] = '1',,,,,,
tox_grade_events_prog3,cancer_history_details,,dropdown,Treatment toxicity grade III-IV events progression 3,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of grade III-IV events as per CTCAE,autocomplete,,,,[clinical_trial_prog3] = '1',,,,,,
tox_dose_reductions_prog3,cancer_history_details,,dropdown,Treatment toxicity dose reductions at progression 3,"0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 11, 11 | 12, 12 | 13, 13 | 14, 14 | 15, 15 | 16, 16 | 17, 17 | 18, 18 | 19, 19 | 20, 20",Specify number of chemotherapy dose reductions due to toxicity,autocomplete,,,,[clinical_trial_prog3] = '1',,,,,,
radiation_therapy_prog3,cancer_history_details,,dropdown,Radiation therapy at progression 3,"1, Yes | 0, No | 9999, Unknown",Whether the subject received radiation therapy for this disease phase,autocomplete,,,,[add_prog_num3]='3',,,,,,
tumor_seq_data_prog3,cancer_history_details,"<div class=""rich-text-field-label""><p style=""text-align: center;""><span style=""color: #001eff;"">Biologic Specimen</span></p></div>",checkbox,Tumor sequencing data at progression 3,"1, DNA panel | 2, Whole exome | 3, Whole genome | 4, RNASeq | 5, Methylome | 9998, Other | 9996, N/A",Type of sequencing data available for this tumor diagnosis,,,,,[add_prog_num3]='3',,,,,,
other_tumor_seq_data_prog3,cancer_history_details,,text,Other tumor sequencing data at progression 3,,Specify the type of sequencing data,,,,,[tumor_seq_data_prog3(9998)] = '1',,,,,,
family_status,inheritance,,dropdown,Familial status of CPS,"1, Inherited | 2, De Novo | 9999, Unknown",Whether the CPS is inherited or not,autocomplete,,,,,y,,,,,
fu_age,followup,,text,Age at follow-up (in months),,,,,,,,,,,,, @READONLY
fu_surv_status,followup,,dropdown,Survival status,"1, Alive | 2, Dead",,autocomplete,,,,,,,,,,
death_age,followup,,text,Age at death (in months),,,,,,,[fu_surv_status] = '2',,,,,, @READONLY
death_cause,followup,,dropdown,Cause of death,"1, Death due to disease progression | 2, Treatment-related mortality | 9998, Other | 9999, Unknown | 9997, Not reported",The cause of death,autocomplete,,,,[fu_surv_status] = '2',y,,,,,
other_death_cause,followup,,text,Other cause of death ,,Specify death cause ,,,,,[death_cause] = '9998',y,,,,,